|Company Profile|| :|
Company Profile –
SMILAX is a part of a gigantic parent group Called “RAMKY”. Ramky is 1.3 Billion Dollar Company with CAGR of more than 50%.
SMILAX is well expertised in Manufacturing APIs, Drug Intermediates & Pellets for global generic MNCs/brand pharma companies since 2005.
Smilax Labs is a company backed by a heritage of Trust and Credibility. We pledge to build on our legacy by working hard on a daily basis to earn the trust of customers.
Received “ Outstanding Exports award” in Emerging small companies category from Government of India for 2009 –10 and expected even for the current 2010-2011
Smilax is an Approved Vendor to many prestigious clients, who are among the Top 5 in USA, EU, Japan, Korea, India etc…
All key functions in various departments are headed by best in class pharma professionals.
Manufacturing Facilities –
We have 2 State of art manufacturing facilities well Equipped with cGMP compliant manufacturing norms. All our Manufacturing facilities are located in the Indian cities Hyderabad and Vishakhapatnam.
Total Plant built up Area of the facility in Vishakhapatnam is 350,000 Sq.ft and invested about US$70 Million for the infra structure.
One more facility is under construction especially to meet regulated markets requirements & Standards.
Multi- product manufacturing facilities maximize the flexibility of operation processes and capabilities.
Set up 495 KL multiple blocks facility at Pharma city, Visakhapatnam in 2009 and now we aim to reach 1200KL manufacturing capacity very soon.
We ensure the effectiveness of the QMS through a range of activities such as Internal Audits, Corrective & Preventive actions, External Assessment and strict adherence to protocols of in-house SOPs and GMP norms.
EMEA audited both the facilities recently, successful certification is expected very soon
Received CEP from EDQM in 2010 for product OMEPRAZOLE. Many more products like Sartans and proton pump inhibitors are in pipeline for certifications.
Research & Development
Focus of R&D is to develop new products, improving quality of existing products & Non Infringing process developments.
A state of the art R&D centre is set up with an investment of US$12Mn.
R&D is well equipped with a Kilo Lab Facility, HPLCs, GCs, FTIR, UV Spectrophotometer, Auto Titrators, Digital Polarimeter & Stability chambers
The R&D is driven by 40 well Qualified and Experienced scientists.
As an outcome we are about to file US DMF for few products within few months.